- Home
- ESE vs PCVX Comparison
ESE vs PCVX Comparison
Compare ESE & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESE | PCVX |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.6B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ESE | PCVX |
|---|---|---|
| Price | $325.80 | $58.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $283.33 | $88.25 |
| AVG Volume (30 Days) | 306.0K | ★ 963.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | ★ 193.15 | N/A |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $37,000,000.00 | N/A |
| Revenue This Year | $21.42 | N/A |
| Revenue Next Year | $6.99 | N/A |
| P/E Ratio | $295.68 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $162.74 | $28.09 |
| 52 Week High | $330.00 | $65.00 |
Technical Indicators
Market Signals| Indicator | ESE | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 47.83 |
| Support Level | $198.85 | $52.04 |
| Resistance Level | N/A | $58.95 |
| Average True Range (ATR) | 10.30 | 2.12 |
| MACD | -0.21 | -0.52 |
| Stochastic Oscillator | 90.27 | 32.38 |
Price Performance
Historical ComparisonAbout ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.